![]() |
Life Science Instrumentation Market |
The life science instrumentation market has witnessed significant growth over the past few years owing to the increasing prevalence of chronic and infectious diseases worldwide. Life science instrumentation finds wide applications across different industries including biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, academic & research institutions, and other end users. Growing focus on developing personalized medicine along with rising R&D investments in the healthcare sector have boosted the demand for advanced life science analytical instruments.
The global life science instrumentation market is estimated to be valued at US$ 84.11 billion in 2024 and is expected to exhibit a CAGR of 6.3% over the forecast period from 2024 to 2031.
Increasing incidence of chronic diseases, technological advancements in instrumentation techniques, and rising expenditure on healthcare research are some of the key factors fueling Life Science Instrumentation Market Demand growth. Additionally, growing government initiatives to support life science research along with rising outsourcing activities by CROs & pharmaceutical companies are further propelling the demand for analytical instruments across the globe.
Key Takeaways
Key players operating in the life science instrumentation market are Agilent Technologies, Danaher Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc., Bruker Corporation, Waters Corporation, GE Healthcare, Shimadzu Corporation, PerkinElmer Inc., Illumina, Inc., Qiagen N.V., Merck KGaA, Abbott Laboratories, Hitachi High-Technologies Corporation, Roche Diagnostics, Beckman Coulter, Inc., and Eppendorf AG. The rising number of genomics projects and high demand for analytical techniques in drug discovery are offering significant growth opportunities. Moreover, emerging markets such as Asia Pacific and Latin America are attracting major players owing to low-cost manufacturing and availability of skilled labor.
Market Drivers
Increasing R&D investments by pharmaceutical and biotechnology companies: Growing R&D expenditure by pharma/biotech firms on drug discovery and development is a major factor driving the demand for analytical instruments. Comprehensive characterization of drug candidates requires sophisticated analytical techniques, thereby fuelling the life science instrumentation market growth.
Rising prevalence of chronic and infectious diseases: Changing disease patterns with increasing prevalence of lifestyle diseases, cancer, and viral infections have augmented the need for early diagnosis and laboratory testing. This has accelerated the adoption of technologically advanced analytical systems.
Market Restraints
High cost of advanced Life Science Instrumentation Market Size and Trends analytical instruments: Chromatography, spectroscopy, and specific disease diagnostic systems with high-end features come at a very high price which restraint its adoption, particularly in price-sensitive developing nations.
Requirement of skilled professionals to operate instruments: Advanced life science analytical instruments require trained professionals to properly operate, maintain, and interpret results. Availability of qualified technicians remains a challenge, especially in remote areas.
Segment Analysis
The life science instrumentation market can be segmented based on technology into spectrometry, chromatography, polymerase chain reaction, electrophoresis, nucleic acid microarrays, microscopy, next-generation sequencing, flow cytometry, centrifuges, and other technologies. The spectrometry segment is dominating currently due to rising usage of various spectrometry technologies like mass spectrometry and molecular spectroscopy techniques in life science research. These spectrometry technologies aid in identification, quantification and characterization of biological samples.
Global Analysis
North America currently dominates the life science instrumentation market owing to presence of large pharmaceutical companies undertaking drug discovery activities along with growing biotechnology and biopharmaceutical industries in the region. Rise in R&D expenditure by public and private organizations in the fields of genomics and proteomics is also driving market growth in North America. Asia Pacific is projected to grow at the fastest rate during the forecast period. This is attributed to expansion of research infrastructure, growth in pharmaceutical industry, increasing government funding for life science research, and rising outsourcing of clinical research activities in countries like China and India.
Get more insights on Life Science Instrumentation Market
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
Comments
Post a Comment